Cargando…
Ketoconazole as second-line treatment for Cushing’s disease after transsphenoidal surgery: systematic review and meta-analysis
INTRODUCTION: The first-line treatment for Cushing’s disease is transsphenoidal surgery for pituitary tumor resection. Ketoconazole has been used as a second-line drug despite limited data on its safety and efficacy for this purpose. The objective of this meta-analysis was to analyze hypercortisolis...
Autores principales: | Viecceli, Camila, Mattos, Ana Carolina Viana, Hirakata, Vânia Naomi, Garcia, Sheila Piccoli, Rodrigues, Ticiana da Costa, Czepielewski, Mauro Antônio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200879/ https://www.ncbi.nlm.nih.gov/pubmed/37223017 http://dx.doi.org/10.3389/fendo.2023.1145775 |
Ejemplares similares
-
Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
por: Viecceli, Camila, et al.
Publicado: (2022) -
Is cushing's syndrome remission associated with diabetes regression? Analysis of a retrospective cohort of 108 patients with cushing's disease
por: Londero, Thizá Massaia, et al.
Publicado: (2015) -
Enhancing Cushing’s disease diagnosis: exploring the impact of desmopressin on ACTH gradient during BIPSS
por: de Almeida, Tobias Skrebsky, et al.
Publicado: (2023) -
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022) -
Outcomes of endoscopic transsphenoidal surgery for Cushing's disease
por: Brady, Zarina, et al.
Publicado: (2021)